— Know what they know.
Not Investment Advice
Also trades as: IBM.TO (TSX) · $vol 3M · IBM.L (LSE) · $vol 2M · IBM.DE (XETRA) · $vol 2M · IBM.NE (NEO) · $vol 1M · IBMA.BR (BRU) · $vol 0M

IBM NYSE

International Business Machines Corporation
1W: +3.4% 1M: +13.4% 3M: +11.3% YTD: -13.7% 1Y: -18.2% 3Y: +96.1% 5Y: +119.0%
$250.25
-3.19 (-1.26%)
 
Weekly Expected Move ±3.7%
$235 $244 $254 $263 $272
NYSE · Technology · Information Technology Services · Tech Score Buy · Power 72 · $236.5B mcap · 943M float · 0.841% daily turnover · Short 43% of daily vol
Credit Risk of going bust: higher than 57% of companies Debt: 22.1% of company value Bonds: $953.4M held by 312 funds, 90 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $7.35 (down 97%), International Business Machines Corporation would be worth roughly what it owes.
Total debt $67.14B against a stock market value of $236.52B.
Distance to default 4.46 (Merton model): prices to 2026-10-27, balance sheet 2026-09-30, debt counted $36.16B (short-term plus half of long-term), stock volatility 50.4%; Altman Z'' 3.92. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
66.8 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 13.8%  ·  5Y Avg: 8.7%
Cost Advantage
54
Intangibles
95
Switching Cost
45
Network Effect
55
Scale
85
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IBM has a Narrow competitive edge (66.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Intangible Assets. ROIC of 13.8% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$240
Low
$264
Avg Target
$300
High
Based on 10 analysts since Oct 21, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 23Hold: 23Sell: 5Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$259.67
Analysts12
Consensus Change History
DateFieldFromTo
2026-06-24 consensus Hold Buy
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-22 BMO Capital — $230 $265 +35 +6.5% $248.85
2026-10-22 Truist Financial — $240 $260 +20 +5.4% $246.57
2026-10-22 Stifel Nicolaus David Grossman $235 $260 +25 +3.4% $251.46
2026-10-22 Susquehanna — $235 $256 +21 +1.8% $251.46
2026-10-22 Goldman Sachs — $270 $300 +30 +19.3% $251.46
2026-10-22 UBS David Vogt $345 $243 -102 -3.4% $251.46
2026-10-22 Robert W. Baird — $230 $260 +30 +3.4% $251.46
2026-10-22 Morgan Stanley — $190 $240 +50 -4.6% $251.46
2026-10-22 Barclays Raimo Lenschow $262 $277 +15 +10.2% $251.46
2026-10-22 Jefferies Brent Thill $260 $280 +20 +11.3% $251.46
2026-10-09 Truist Financial Arvind Ramnani Initiated $240 — +5.9% $226.61
2026-08-31 Susquehanna James Friedman $225 $235 +10 +0.6% $233.51
2026-07-24 Susquehanna James Friedman $303 $225 -78 +6.1% $211.99
2026-07-23 BMO Capital — $270 $230 -40 +13.0% $203.62
2026-07-23 Goldman Sachs — $250 $270 +20 +31.2% $205.77
2026-07-23 Morgan Stanley — $293 $190 -103 -7.7% $205.77
2026-07-23 Barclays — $288 $262 -26 +27.3% $205.77
2026-07-21 Robert W. Baird — Initiated $230 — +9.3% $210.50
2026-07-21 RBC Capital Matthew Swanson $330 $270 -60 +28.2% $210.66
2026-07-21 Barclays Raimo Lenschow $350 $288 -62 +35.2% $213.00
2026-07-21 Jefferies Brent Thill $320 $260 -60 +22.1% $213.00
2026-07-20 Stifel Nicolaus David Grossman $290 $235 -55 +10.5% $212.67
2026-07-16 HSBC Abhishek Shukla $191 $175 -16 -18.2% $214.05
2026-07-16 Argus Research Jim Kelleher $360 $280 -80 +33.0% $210.50
2026-07-14 Oppenheimer — $320 $350 +30 +59.1% $220.02
2026-07-14 Morgan Stanley — $267 $293 +26 +1.0% $290.23
2026-07-14 HSBC — $231 $191 -40 -34.2% $290.23
2026-07-10 Susquehanna — Initiated $303 — +2.6% $295.30
2026-06-23 Morgan Stanley — $225 $267 +42 +5.9% $252.22
2026-06-02 Wedbush — $320 $350 +30 +9.2% $320.42
2026-06-01 Barclays Raimo Lenschow Initiated $350 — +17.5% $297.80
2026-05-22 Stifel Nicolaus David Grossman $340 $290 -50 +14.6% $252.97
2026-04-27 HSBC — Initiated $231 — +1.3% $228.05
2026-04-23 Morgan Stanley — $215 $225 +10 -0.7% $226.53
2026-04-23 BMO Capital — $350 $270 -80 +20.2% $224.71
2026-04-23 Wedbush Daniel Ives $340 $320 -20 +27.1% $251.86
2026-04-20 Jefferies — $370 $320 -50 +26.2% $253.47
2026-04-17 RBC Capital Matthew Swanson $361 $330 -31 +30.3% $253.25
2026-04-16 Oppenheimer — $380 $320 -60 +29.4% $247.37
2026-04-14 Morgan Stanley Erik Woodring $304 $215 -89 -9.6% $237.82
2026-01-30 Argus Research — $165 $360 +195 +18.4% $304.06
2026-01-29 UBS — $317 $345 +28 +13.5% $303.99
2026-01-29 RBC Capital Matthew Swanson $350 $361 +11 +16.1% $310.87
2026-01-29 Oppenheimer Param Singh $360 $380 +20 +21.0% $314.15
2026-01-29 Stifel Nicolaus — $325 $340 +15 +8.1% $314.44
2026-01-29 Evercore ISI — $330 $345 +15 +10.0% $313.63
2026-01-29 Wedbush Daniel Ives $140 $340 +200 +15.6% $294.16
2026-01-29 BMO Capital Keith Bachman $305 $350 +45 +19.0% $294.16
2026-01-29 UBS — $236 $317 +81 +1.4% $312.55
2026-01-29 UBS David Vogt $210 $236 +26 -19.8% $294.16

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 27, 2026
DCF
4
ROE
5
ROA
4
D/E
1
P/E
3
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IBM receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (5/5), ROA (4/5). Areas of concern: D/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-22 B B+
2026-08-28 B+ B
2026-08-27 B B+
2026-08-04 B+ B
2026-07-23 A- B+
2026-07-22 C A-
2026-07-14 B+ C
2026-07-01 B B+
2026-06-23 B+ B
2026-06-22 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 68 Grade B
Profitability
65
Balance Sheet
34
Earnings Quality
74
Growth
65
Value
52
Momentum
89
Safety
80
Cash Flow
67
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IBM scores highest in Momentum (89/100) and lowest in Balance Sheet (34/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.15
Safe Zone
Piotroski F-Score
6/9
✓ ✓ ✓ ✓ ✓ ✗ ✗ ✗ ✓
Beneish M-Score
-2.47
Unlikely Manipulator
Ohlson O-Score
-7.55
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB
Score: 55.9/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.42x
Accruals: -3.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IBM scores 3.15, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IBM scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. IBM's score of -2.47 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IBM's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IBM receives an estimated rating of BBB (score: 55.9/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). IBM's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
21.03x
PEG
0.53x
P/S
3.39x
P/B
6.65x
P/FCF
15.18x
P/OCF
13.25x
EV/EBITDA
14.99x
EV/Revenue
3.80x
EV/EBIT
21.37x
EV/FCF
19.24x
Earnings Yield
5.33%
FCF Yield
6.59%
Shareholder Yield
3.49%
Graham Number
$99.11
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 21.0x earnings, IBM commands a growth premium. An earnings yield of 5.3% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $99.11 per share, 152% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.063
NI / EBT
×
Interest Burden
0.845
EBT / EBIT
×
EBIT Margin
0.178
EBIT / Rev
×
Asset Turnover
0.464
Rev / Assets
×
Equity Multiplier
4.750
Assets / Equity
=
ROE
35.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IBM's ROE of 35.2% is driven by financial leverage (equity multiplier: 4.75x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.06 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$451.01
Price/Value
0.49x
Margin of Safety
51.24%
Premium
-51.24%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with IBM's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. IBM actually compounded EPS at 16.0% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. IBM trades at a -51% premium to its adjusted intrinsic value of $451.01, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 21.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$250.24
Median 1Y
$271.60
5th Pctile
$159.49
95th Pctile
$465.24
Ann. Volatility
31.4%
Analyst Target
$259.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
V.M. Rometty Chairman,
President and CEO
$1,500,000 $12,460,409 $19,345,125
K.M. Keverian VP,
ior VP, Corporate Strategy
$450,000 $11,279,227 $9,560,445
S.A. Mills VP,
cutive VP, Software and Systems
$730,500 $4,886,428 $8,270,052
J.E. Kelly III
Senior VP, Solutions Portfolio & Research
$638,000 $3,909,248 $6,570,826
M.J. Schroeter VP
nior VP and CFO
$660,000 $3,616,006 $5,112,899

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
—
-100.0% YoY
Revenue / Employee
—
Rev: $67,535,000,000
Profit / Employee
—
NI: $10,593,000,000
SGA / Employee
—
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 29.1% 27.3% 27.0% 6.0% 8.0% 9.0% 9.7% 32.1% 33.7% 36.5% 36.5% 26.9% 24.2% 21.8% 22.6% 30.2% 35.3% 35.9% 34.6% 35.2% 35.21%
ROA 4.0% 3.9% 4.1% 0.9% 1.3% 1.4% 1.6% 5.4% 5.7% 6.0% 6.3% 4.9% 4.4% 3.9% 4.1% 5.6% 7.3% 7.1% 7.1% 7.4% 7.41%
ROIC 10.0% 10.2% 10.7% 23.0% 18.8% 16.6% 15.4% 11.4% 12.3% 13.9% 13.5% 14.6% 14.7% 12.6% 12.8% 12.0% 14.0% 13.5% 13.1% 13.8% 13.77%
ROCE 6.1% 6.5% 7.6% 2.0% 2.5% 2.8% 3.3% 9.9% 10.2% 9.9% 10.2% 7.5% 7.2% 6.9% 7.3% 10.2% 10.8% 10.8% 10.6% 10.5% 10.49%
Gross Margin 56.9% 51.7% 53.4% 52.7% 57.7% 52.7% 54.9% 54.4% 59.1% 53.5% 56.8% 56.3% 59.5% 55.2% 58.8% 58.7% 61.6% 56.2% 57.7% 56.8% 56.80%
Operating Margin 17.8% 8.3% 12.6% 11.1% 21.0% 10.1% 14.7% 14.3% 23.0% 10.8% 15.4% 14.5% 22.2% 12.1% 18.2% 16.3% 21.2% 13.9% 15.2% 16.8% 16.84%
Net Margin 14.0% 5.2% 9.0% -22.7% 16.2% 6.5% 10.2% 11.6% 18.9% 11.1% 11.6% -2.2% 16.6% 7.3% 12.9% 10.7% 28.4% 7.6% 12.6% 12.8% 12.80%
EBITDA Margin 27.3% 15.4% 21.0% -21.6% 28.5% 17.5% 22.6% 22.9% 30.6% 18.2% 24.1% 6.0% 27.6% 19.2% 25.8% 25.7% 30.1% 19.7% 25.1% 25.5% 25.53%
FCF Margin 17.5% 14.7% 12.6% 11.6% 14.0% 14.8% 17.0% 18.8% 19.6% 20.3% 19.4% 19.0% 18.7% 19.0% 18.4% 19.9% 18.2% 19.0% 20.2% 19.8% 19.77%
OCF Margin 22.3% 19.1% 16.5% 14.9% 17.2% 18.1% 20.3% 22.0% 22.5% 23.1% 22.1% 21.7% 21.4% 21.7% 20.7% 20.6% 19.5% 20.3% 21.5% 22.7% 22.66%
ROE 3Y Avg snapshot only 28.64%
ROE 5Y Avg snapshot only 24.44%
ROA 3Y Avg snapshot only 5.79%
ROIC 3Y Avg snapshot only 11.08%
ROIC Economic snapshot only 12.46%
Cash ROA snapshot only 10.21%
Cash ROIC snapshot only 17.28%
CROIC snapshot only 15.08%
NOPAT Margin snapshot only 18.06%
Pretax Margin snapshot only 15.04%
R&D / Revenue snapshot only 12.95%
SGA / Revenue snapshot only 28.29%
SBC / Revenue snapshot only 1.49%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio 17.98 18.51 20.13 75.45 70.52 59.52 55.87 17.41 19.02 20.69 18.38 30.87 33.53 42.15 47.26 33.68 26.63 21.46 24.98 18.77 21.029
P/S Ratio 1.80 1.75 1.88 1.57 1.91 1.80 1.87 1.97 2.31 2.73 2.48 3.16 3.22 3.67 4.30 4.07 4.18 3.35 3.88 3.00 3.385
P/B Ratio 5.46 5.36 5.79 4.74 5.27 5.05 5.10 5.22 6.33 7.27 6.45 8.08 7.40 8.58 10.02 9.54 8.64 7.00 7.78 5.90 6.650
P/FCF 10.30 11.91 14.94 13.60 13.67 12.17 10.99 10.47 11.77 13.42 12.81 16.61 17.17 19.32 23.34 20.42 22.97 17.63 19.19 15.18 15.179
P/OCF 8.07 9.18 11.45 10.55 11.08 9.96 9.21 8.97 10.24 11.81 11.27 14.54 15.02 16.90 20.76 19.75 21.38 16.49 18.00 13.25 13.248
EV/EBITDA 12.18 12.03 12.37 20.01 22.43 20.51 20.36 11.89 12.88 14.36 13.29 19.28 20.18 22.72 25.42 19.61 19.37 16.38 18.50 14.99 14.988
EV/Revenue 2.64 2.56 2.65 2.30 2.66 2.53 2.60 2.75 3.06 3.43 3.22 3.90 3.92 4.46 5.12 4.86 4.96 4.19 4.70 3.80 3.804
EV/EBIT 25.22 23.31 21.90 72.64 67.84 53.59 48.10 17.23 18.37 20.52 18.97 30.71 32.73 36.77 40.60 27.96 27.30 23.08 26.28 21.37 21.374
EV/FCF 15.07 17.39 21.02 19.92 19.02 17.10 15.26 14.60 15.61 16.89 16.63 20.52 20.90 23.46 27.77 24.39 27.25 22.07 23.28 19.24 19.238
Earnings Yield 5.6% 5.4% 5.0% 1.3% 1.4% 1.7% 1.8% 5.7% 5.3% 4.8% 5.4% 3.2% 3.0% 2.4% 2.1% 3.0% 3.8% 4.7% 4.0% 5.3% 5.33%
FCF Yield 9.7% 8.4% 6.7% 7.4% 7.3% 8.2% 9.1% 9.6% 8.5% 7.5% 7.8% 6.0% 5.8% 5.2% 4.3% 4.9% 4.4% 5.7% 5.2% 6.6% 6.59%
PEG Ratio snapshot only 0.530
EV/OCF snapshot only 16.790
EV/Gross Profit snapshot only 6.532
Acquirers Multiple snapshot only 22.375
Shareholder Yield snapshot only 3.49%
Graham Number snapshot only $99.11
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 0.88 0.92 0.88 0.95 0.92 1.16 1.06 0.91 0.96 1.13 1.12 1.06 1.04 1.01 0.91 0.93 0.93 0.80 0.79 0.85 0.855
Quick Ratio 0.83 0.87 0.82 0.89 0.87 1.11 1.01 0.86 0.93 1.09 1.08 1.01 1.00 0.97 0.87 0.89 0.90 0.76 0.74 0.80 0.802
Debt/Equity 2.92 3.02 2.75 2.68 2.46 2.85 2.72 2.54 2.66 2.70 2.49 2.46 2.14 2.49 2.46 2.39 2.06 2.12 1.89 1.89 1.889
Net Debt/Equity 2.53 2.47 2.36 2.20 2.06 2.05 1.98 2.06 2.06 1.88 1.92 1.90 1.60 1.84 1.90 1.85 1.61 1.76 1.66 1.58 1.578
Debt/Assets 0.42 0.43 0.42 0.43 0.42 0.46 0.46 0.45 0.44 0.46 0.45 0.45 0.43 0.46 0.46 0.45 0.44 0.45 0.43 0.43 0.433
Debt/EBITDA 4.44 4.64 4.17 7.73 7.53 8.24 7.81 4.14 4.08 4.24 3.95 4.75 4.80 5.42 5.25 4.11 3.88 3.96 3.71 3.79 3.786
Net Debt/EBITDA 3.86 3.79 3.58 6.35 6.31 5.92 5.70 3.36 3.16 2.95 3.05 3.67 3.60 4.00 4.05 3.19 3.05 3.29 3.25 3.16 3.163
Interest Coverage 5.19 5.40 6.01 1.59 1.95 2.25 2.34 6.44 6.41 6.21 6.33 4.69 4.39 4.39 4.44 6.05 6.34 6.41 6.41 6.45 6.450
Equity Multiplier 6.98 7.00 6.57 6.27 5.80 6.19 5.96 5.60 6.00 5.90 5.57 5.49 5.02 5.42 5.40 5.24 4.65 4.74 4.41 4.36 4.362
Cash Ratio snapshot only 0.303
Debt Service Coverage snapshot only 9.198
Cash to Debt snapshot only 0.165
FCF to Debt snapshot only 0.206
Defensive Interval snapshot only 315.9 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 0.40 0.41 0.44 0.45 0.47 0.45 0.47 0.48 0.47 0.46 0.47 0.47 0.46 0.44 0.45 0.47 0.47 0.46 0.46 0.46 0.464
Inventory Turnover 14.83 14.74 15.72 15.18 17.40 16.41 17.24 17.23 20.32 19.56 20.02 19.67 22.20 20.42 21.87 19.80 22.17 19.45 19.04 17.46 17.461
Receivables Turnover 9.14 9.02 9.01 9.53 9.11 10.34 10.49 11.27 8.99 10.52 10.90 11.67 8.95 10.56 10.91 11.98 6.07 11.16 11.50 12.34 12.338
Payables Turnover 6.48 7.00 6.93 6.95 6.96 7.72 7.38 7.70 6.74 7.53 7.44 8.22 6.66 7.53 7.15 7.66 6.33 7.42 6.82 6.98 6.982
DSO 40 40 40 38 40 35 35 32 41 35 33 31 41 35 33 30 60 33 32 30 29.6 days
DIO 25 25 23 24 21 22 21 21 18 19 18 19 16 18 17 18 16 19 19 21 20.9 days
DPO 56 52 53 53 52 47 49 47 54 48 49 44 55 49 51 48 58 49 54 52 52.3 days
Cash Conversion Cycle 8 13 11 10 9 10 7 6 4 5 3 5 2 4 -1 1 19 2 -3 -2 -1.8 days
Fixed Asset Turnover snapshot only 7.630
Operating Cycle snapshot only 50.5 days
Cash Velocity snapshot only 6.318
Capital Intensity snapshot only 2.219
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue -22.1% -15.7% -8.7% -0.8% 5.5% 3.8% 1.4% 1.1% 2.2% 2.4% 3.0% 2.3% 1.4% 1.2% 2.7% 4.5% 7.6% 9.7% 7.9% 6.8% 6.83%
Net Income 2.8% 2.8% 4.8% -73.5% -71.4% -66.8% -63.8% 4.5% 3.6% 3.5% 3.2% -7.6% -19.7% -33.1% -30.8% 23.6% 75.9% 96.5% 83.9% 41.3% 41.27%
EPS 2.1% 2.0% 4.0% -73.5% -71.8% -67.1% -64.1% 4.4% 3.5% 3.4% 3.1% -7.6% -21.0% -33.9% -31.7% 20.3% 74.0% 95.1% 82.7% 40.6% 40.58%
FCF -33.0% -44.7% -48.2% -46.7% -15.6% 4.5% 36.8% 64.6% 43.2% 40.6% 17.4% 3.2% -3.0% -5.3% -2.4% 9.7% 4.5% 9.6% 18.2% 6.0% 5.96%
EBITDA -1.7% -3.9% 4.8% -37.6% -42.2% -39.7% -39.7% 1.0% 1.0% 98.2% 96.1% -10.5% -17.1% -16.9% -14.7% 28.2% 42.0% 43.0% 36.2% 9.4% 9.38%
Op. Income -30.0% -25.9% -16.8% -2.7% 19.5% 19.2% 17.7% 21.3% 19.6% 17.5% 15.1% 9.1% 2.7% 3.4% 8.3% 12.2% 15.9% 18.0% 6.7% 4.1% 4.09%
OCF Growth snapshot only 17.41%
Asset Growth snapshot only 5.94%
Equity Growth snapshot only 27.35%
Debt Growth snapshot only 0.86%
Shares Change snapshot only 0.49%
Dividend Growth snapshot only 1.26%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y -10.3% -9.5% -8.5% -7.8% -7.8% -7.5% -7.1% -6.6% -5.6% -3.6% -1.5% 0.8% 3.0% 2.5% 2.4% 2.6% 3.7% 4.4% 4.5% 4.5% 4.53%
Revenue 5Y -6.4% -6.0% -5.3% -5.0% -5.2% -5.4% -5.6% -5.3% -4.9% -4.6% -4.3% -4.1% -4.0% -3.9% -3.2% -2.7% -1.7% -0.1% 1.1% 2.7% 2.74%
EPS 3Y -13.0% -14.4% -14.5% -45.5% -44.6% -41.7% -37.0% -5.2% 9.2% 13.8% 15.2% 9.6% 0.2% -1.6% 0.1% 81.5% 83.8% 78.1% 72.3% 16.0% 16.04%
EPS 5Y -12.6% -13.1% -12.8% -35.1% -22.0% -20.1% -18.8% 3.7% -3.4% -1.9% -1.6% -4.3% -9.5% -10.5% -6.9% -1.1% 12.3% 13.7% 13.8% 17.4% 17.37%
Net Income 3Y -13.0% -13.9% -13.8% -45.3% -44.2% -41.2% -36.4% -4.3% 10.3% 15.1% 16.5% 10.3% 1.6% -0.3% 1.4% 84.4% 86.2% 80.3% 74.3% 17.3% 17.28%
Net Income 5Y -13.5% -13.8% -13.3% -35.5% -22.2% -20.2% -18.8% 3.9% -3.0% -1.1% -0.7% -3.7% -8.6% -9.5% -5.8% 0.0% 13.6% 14.9% 15.0% 18.6% 18.58%
EBITDA 3Y -9.1% -11.1% -10.8% -26.2% -25.8% -22.3% -20.1% -2.6% 5.2% 4.7% 7.4% 4.3% -0.6% -0.2% 0.3% 32.5% 34.1% 33.1% 31.6% 7.8% 7.84%
EBITDA 5Y -6.5% -7.0% -5.7% -16.4% -15.4% -14.4% -14.3% -3.1% -2.3% -3.4% -3.4% -6.1% -7.1% -5.0% -3.1% 1.1% 6.5% 6.4% 7.6% 9.7% 9.70%
Gross Profit 3Y -5.2% -4.7% -4.1% -3.4% -3.6% -3.3% -2.8% -2.3% -1.2% -0.1% 1.1% 2.9% 4.1% 4.1% 4.6% 5.3% 6.7% 7.3% 7.0% 6.5% 6.52%
Gross Profit 5Y -3.8% -3.3% -2.6% -2.4% -2.3% -2.4% -2.4% -1.9% -1.5% -1.2% -0.9% -0.4% -0.5% -0.3% 0.4% 1.0% 2.2% 3.2% 3.7% 4.6% 4.59%
Op. Income 3Y -19.8% -19.5% -16.2% -11.7% -8.1% -4.6% -2.9% -2.6% 0.0% 1.3% 4.0% 8.8% 13.6% 13.2% 13.6% 14.1% 12.5% 12.8% 9.9% 8.4% 8.43%
Op. Income 5Y -12.2% -12.2% -10.7% -10.2% -8.5% -7.8% -7.6% -6.6% -5.9% -6.0% -4.5% -1.8% -1.0% 1.1% 2.7% 2.5% 3.6% 4.8% 5.4% 8.5% 8.53%
FCF 3Y -3.9% -9.9% -16.1% -17.2% -10.6% -7.9% -5.3% -3.1% -6.8% -6.7% -5.9% -3.2% 5.5% 11.6% 16.2% 23.1% 13.2% 13.4% 10.7% 6.3% 6.26%
FCF 5Y -4.5% -5.3% -8.1% -8.4% -8.2% -7.8% -3.1% -2.0% 1.4% 1.4% -1.0% -0.7% -0.2% 0.8% -0.5% 0.6% -3.9% -3.4% -0.8% 1.0% 1.03%
OCF 3Y -5.7% -10.3% -15.1% -16.4% -10.9% -8.9% -6.7% -5.2% -8.5% -8.4% -8.0% -5.5% 1.7% 7.0% 10.6% 14.4% 8.1% 8.5% 6.6% 5.6% 5.63%
OCF 5Y -5.3% -6.0% -8.3% -9.3% -9.0% -8.8% -5.4% -4.4% -1.8% -1.4% -3.0% -2.5% -1.9% -1.2% -2.6% -3.1% -6.2% -5.6% -3.4% -0.4% -0.35%
Assets 3Y 2.3% 0.6% -6.2% -5.6% -5.8% -4.5% -5.0% -5.7% -4.6% -2.6% -3.0% -2.3% 1.3% 3.0% 5.2% 5.1% 6.1% 5.3% 4.8% 6.2% 6.23%
Assets 5Y 2.4% 2.6% 1.1% 0.7% 0.3% 1.3% 1.7% 1.2% 1.9% 0.9% -2.8% -2.1% -2.1% -1.0% -0.7% -1.0% -0.5% 1.0% 0.7% 1.5% 1.45%
Equity 3Y 4.0% 4.9% 3.2% 3.8% 1.7% 2.6% 2.6% 2.9% 3.0% 2.8% 3.1% 3.2% 13.0% 12.2% 12.3% 11.6% 14.2% 15.1% 15.8% 15.5% 15.47%
Book Value 3Y 4.0% 4.4% 2.5% 3.4% 0.9% 1.7% 1.7% 1.9% 2.0% 1.7% 1.9% 2.6% 11.5% 10.7% 10.9% 9.8% 12.7% 13.7% 14.4% 14.3% 14.25%
Dividend 3Y 0.4% -0.2% -0.3% 0.0% -0.4% -0.4% -0.4% -0.5% -0.5% -0.6% -0.5% -0.1% -0.8% -0.7% -0.7% -1.0% -0.7% -0.6% -0.6% -0.5% -0.48%
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.63 0.74 0.78 0.76 0.76 0.87 0.91 0.83 0.71 0.74 0.72 0.58 0.40 0.43 0.40 0.36 0.20 0.01 0.16 0.76 0.758
Earnings Stability 0.40 0.43 0.49 0.69 0.41 0.43 0.49 0.13 0.31 0.21 0.15 0.08 0.10 0.07 0.01 0.05 0.34 0.35 0.38 0.69 0.695
Margin Stability 0.93 0.93 0.93 0.93 0.92 0.93 0.93 0.92 0.92 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.93 0.94 0.95 0.96 0.962
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.99 0.99 0.98 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.97 0.92 0.87 0.88 0.91 0.50 0.50 0.50 0.83 0.835
Earnings Smoothness 0.97 0.97 0.95 0.00 0.00 0.00 0.06 0.00 0.00 0.00 0.00 0.92 0.78 0.60 0.64 0.79 0.45 0.35 0.41 0.66 0.658
ROE Trend -0.06 -0.06 -0.03 -0.23 -0.21 -0.19 -0.17 0.16 0.14 0.16 0.16 0.08 0.02 -0.01 -0.01 0.00 0.05 0.05 0.03 0.04 0.042
Gross Margin Trend 0.07 0.06 0.04 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.02 0.01 0.009
FCF Margin Trend -0.00 -0.04 -0.07 -0.08 -0.05 -0.04 -0.00 0.02 0.04 0.06 0.05 0.04 0.02 0.01 0.00 0.01 -0.01 -0.01 0.01 0.00 0.003
Sustainable Growth Rate -0.6% -1.8% -1.6% -22.1% -21.1% -20.3% -19.1% 4.2% 6.6% 9.4% 10.1% 1.2% -0.5% -2.8% -1.4% 6.4% 14.5% 14.9% 14.3% 15.2% 15.24%
Internal Growth Rate — — — — — — — 0.7% 1.1% 1.6% 1.8% 0.2% — — — 1.2% 3.1% 3.1% 3.0% 3.3% 3.31%
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 2.23 2.02 1.76 7.15 6.36 5.98 6.06 1.94 1.86 1.75 1.63 2.12 2.23 2.49 2.28 1.71 1.25 1.30 1.39 1.42 1.417
FCF/OCF 0.78 0.77 0.77 0.78 0.81 0.82 0.84 0.86 0.87 0.88 0.88 0.88 0.87 0.87 0.89 0.97 0.93 0.94 0.94 0.87 0.873
FCF/Net Income snapshot only 1.237
OCF/EBITDA snapshot only 0.893
CapEx/Revenue 4.8% 4.4% 3.8% 3.3% 3.3% 3.3% 3.3% 3.1% 2.9% 2.8% 2.7% 2.7% 2.7% 2.7% 2.3% 0.7% 1.3% 1.3% 1.3% 2.9% 2.88%
CapEx/Depreciation snapshot only 0.380
Accruals Ratio -0.05 -0.04 -0.03 -0.06 -0.07 -0.07 -0.08 -0.05 -0.05 -0.05 -0.04 -0.05 -0.05 -0.06 -0.05 -0.04 -0.02 -0.02 -0.03 -0.03 -0.031
Sloan Accruals snapshot only -0.054
Cash Flow Adequacy snapshot only 1.896
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 5.7% 5.8% 5.3% 6.2% 5.1% 5.5% 5.3% 5.0% 4.2% 3.6% 3.9% 3.1% 3.0% 2.7% 2.2% 2.3% 2.2% 2.7% 2.4% 3.0% 2.69%
Dividend/Share $6.49 $6.47 $6.49 $6.56 $6.49 $6.50 $6.52 $6.51 $6.51 $6.50 $6.52 $6.63 $6.52 $6.53 $6.55 $6.56 $6.57 $6.60 $6.62 $6.64 $6.74
Payout Ratio 1.0% 1.1% 1.1% 4.7% 3.6% 3.3% 3.0% 86.9% 80.5% 74.1% 72.2% 95.7% 1.0% 1.1% 1.1% 78.8% 59.0% 58.4% 58.8% 56.7% 56.72%
FCF Payout Ratio 58.5% 68.6% 78.5% 84.7% 70.3% 66.5% 58.2% 52.2% 49.8% 48.1% 50.4% 51.5% 52.3% 51.7% 52.5% 47.8% 50.9% 48.0% 45.2% 45.9% 45.86%
Total Payout Ratio 1.1% 1.1% 1.1% 5.0% 3.9% 3.5% 3.1% 92.9% 85.9% 80.3% 78.3% 1.1% 1.1% 1.2% 1.1% 78.8% 60.6% 63.2% 64.7% 65.5% 65.53%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.07 0.07 0.07 0.08 0.06 0.07 0.07 0.06 0.06 0.05 0.06 0.05 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.048
Buyback Yield 0.3% 0.4% 0.4% 0.4% 0.4% 0.4% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% 0.1% 0.1% 0.0% 0.1% 0.2% 0.2% 0.5% 0.47%
Net Buyback Yield 0.3% 0.4% 0.4% 0.4% 0.4% 0.4% 0.3% 0.3% 0.3% 0.3% 0.3% 0.3% -0.1% -0.1% -0.2% -0.3% -0.0% 0.0% -0.0% 0.1% 0.12%
Total Shareholder Return 6.0% 6.1% 5.6% 6.6% 5.5% 5.9% 5.6% 5.3% 4.5% 3.9% 4.3% 3.4% 2.9% 2.5% 2.1% 2.0% 2.2% 2.7% 2.3% 3.1% 3.14%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 1.19 1.06 0.93 1.77 1.42 1.15 1.08 0.84 0.86 0.94 0.94 1.02 1.04 0.93 0.93 0.83 1.03 1.02 1.03 1.06 1.063
Interest Burden (EBT/EBIT) 0.81 0.81 0.83 0.37 0.49 0.56 0.57 0.84 0.84 0.84 0.84 0.79 0.77 0.77 0.77 0.83 0.84 0.84 0.84 0.84 0.845
EBIT Margin 0.10 0.11 0.12 0.03 0.04 0.05 0.05 0.16 0.17 0.17 0.17 0.13 0.12 0.12 0.13 0.17 0.18 0.18 0.18 0.18 0.178
Asset Turnover 0.40 0.41 0.44 0.45 0.47 0.45 0.47 0.48 0.47 0.46 0.47 0.47 0.46 0.44 0.45 0.47 0.47 0.46 0.46 0.46 0.464
Equity Multiplier 7.29 6.97 6.63 6.38 6.35 6.57 6.24 5.91 5.90 6.04 5.76 5.55 5.47 5.64 5.48 5.36 4.82 5.04 4.85 4.75 4.750
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $6.35 $6.07 $6.13 $1.39 $1.79 $2.00 $2.20 $7.50 $8.09 $8.76 $9.02 $6.93 $6.39 $5.79 $6.16 $8.33 $11.12 $11.30 $11.26 $11.71 $11.71
Book Value/Share $20.89 $20.95 $21.31 $22.21 $23.96 $23.54 $24.15 $24.99 $24.30 $24.92 $25.71 $26.47 $28.98 $28.43 $29.06 $29.41 $34.28 $34.63 $36.16 $37.27 $38.34
Tangible Book/Share $-54.44 $-54.30 $-51.83 $-49.89 $-49.34 $-49.57 $-48.59 $-51.74 $-52.50 $-50.38 $-48.85 $-51.68 $-46.75 $-54.55 $-55.19 $-53.98 $-48.78 $-59.19 $-56.79 $-55.56 $-55.56
Revenue/Share $63.40 $64.19 $65.53 $66.95 $66.09 $66.01 $65.83 $66.22 $66.71 $66.50 $66.74 $67.75 $66.59 $66.46 $67.64 $68.92 $70.91 $72.38 $72.53 $73.27 $73.98
FCF/Share $11.09 $9.44 $8.27 $7.74 $9.24 $9.77 $11.20 $12.47 $13.07 $13.51 $12.94 $12.87 $12.48 $12.63 $12.47 $13.74 $12.90 $13.75 $14.66 $14.49 $15.19
OCF/Share $14.14 $12.24 $10.79 $9.97 $11.39 $11.94 $13.35 $14.54 $15.02 $15.35 $14.72 $14.70 $14.27 $14.44 $14.03 $14.21 $13.85 $14.69 $15.63 $16.60 $16.76
Cash/Share $8.01 $11.53 $8.30 $10.58 $9.54 $18.95 $17.73 $11.89 $14.49 $20.48 $14.65 $14.84 $15.48 $18.47 $16.32 $15.65 $15.19 $12.38 $8.54 $11.60 $11.71
EBITDA/Share $13.72 $13.64 $14.05 $7.70 $7.83 $8.15 $8.39 $15.31 $15.84 $15.89 $16.19 $13.70 $12.92 $13.04 $13.63 $17.09 $18.15 $18.52 $18.44 $18.60 $18.60
Debt/Share $60.95 $63.29 $58.61 $59.54 $58.97 $67.20 $65.59 $63.36 $64.63 $67.36 $64.04 $65.10 $61.97 $70.69 $71.53 $70.15 $70.51 $73.31 $68.51 $70.41 $70.41
Net Debt/Share $52.94 $51.76 $50.31 $48.95 $49.43 $48.25 $47.86 $51.48 $50.14 $46.88 $49.39 $50.26 $46.48 $52.22 $55.21 $54.50 $55.32 $60.94 $59.98 $58.82 $58.82
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.148
Altman Z-Prime snapshot only 5.461
Piotroski F-Score 5 4 5 6 6 6 5 5 6 7 8 8 7 4 4 6 6 7 6 6 6
Beneish M-Score -2.68 -3.19 -2.79 -3.31 -2.81 -2.86 -3.37 -1.96 -1.82 -1.89 -1.87 -2.72 -2.74 -2.70 -2.59 -2.57 -2.33 -2.35 -2.48 -2.47 -2.468
Ohlson O-Score snapshot only -7.552
Net-Net WC snapshot only $-91.89
EVA snapshot only $3454237908.06
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only BBB
Credit Score 47.53 47.36 48.32 36.76 37.37 40.74 41.62 52.92 53.56 55.87 57.45 50.76 53.35 48.74 47.53 52.80 59.88 51.56 54.64 55.89 55.886
Credit Grade snapshot only 9
Credit Trend snapshot only 3.091
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 39
Sector Credit Rank snapshot only 31

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms